Agenda-setting intelligence, analysis and advice for the global fashion community.
British pharmacy chain Boots has chosen outgoing Currys chief executive Alex Baldock to lead the business as it prepares for a potential London stock market listing, Sky News reported on Wednesday.
Baldock, who oversaw a turnaround at the electrical goods retailer during an eight-year tenure, is expected to take the helm at Boots later in 2026, with an announcement likely in the spring, Sky News said, citing retail industry sources.
Here are some details:
- Currys announced Baldock’s departure in March. Sebastian James, the previous CEO of Dixons Carphone, now known as Currys, also departed to run Boots in 2018.
- Private equity firm Sycamore Partners took Boots’ parent Walgreens Boots Alliance private last year in a deal valued at about $10 billion, after which Boots became a standalone entity.
- In April, Reuters reported that Boots’ owners are working with consultants on a strategy overhaul ahead of a potential London IPO as soon as 2027, citing people familiar with the matter.
- Boots operates more than 1,800 stores across Britain, offering pharmacy services, health products and beauty brands including Soap & Glory. It is also a major provider of National Health Service-funded pharmacy services.
- Boots did not immediately respond to Reuters request for comment.
By Nithyashree R B
ADVERTISEMENT
Learn more:
Why Drugstore Beauty Is Succeeding Everywhere Except the US
Within a crowded beauty market, US drugstores are struggling to compete — while their overseas counterparts continue to thrive. To regain relevance and bring success home, American chains must evolve.
